<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04702139</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02470-39</org_study_id>
    <nct_id>NCT04702139</nct_id>
  </id_info>
  <brief_title>Use of the &quot;Game-Ready&quot; Splint for Better Recovery in Primary Total Shoulder Arthroplasty</brief_title>
  <acronym>game-ready</acronym>
  <official_title>Use of the &quot;Game-Ready&quot; Splint for Better Recovery in Primary Total Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinique Bizet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinique Bizet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the level of postoperative pain after fitting the Game&#xD;
      Ready splint, at 48 hours versus that observed with fitting a standard splint&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the level of postoperative pain following the installation of the Game Ready</measure>
    <time_frame>9 months</time_frame>
    <description>Visual Analog Score for pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>risk of stiffness</measure>
    <time_frame>up to 9 months</time_frame>
    <description>Physicians Global Assessment to measure risk of stiffness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of hematoma, edema</measure>
    <time_frame>up to 9 months</time_frame>
    <description>Physicians Global Assessment to measure the occurrence of hematoma, edema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospitalization</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Physicians Global Assessment to measure the length of hospitalisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evolution of mobility</measure>
    <time_frame>up to 9 months</time_frame>
    <description>Simple shoulder test, subjective shoulder value, and American Shoulder and Elbow Surgeons Shoulder Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the time limit for returning to a possible professional activity</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Physicians Global Assessment to measure quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Shoulder Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>patient with game-ready splint</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Installation of the Game-Ready splint immediately after surgery for 12 hours. They will then be put on the standard splint which they will keep for 2 weeks as for the other group but without ice packs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patient with standard splint</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placement of a standard splint immediately after surgery for 2 weeks with ice packs to be used for an average of 8 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>shoulder arthroplastis</intervention_name>
    <description>- Group (Treatment): Placement of the Game-Ready splint immediately after surgery for 12 hours. They will then be put on the standard splint which they will keep for 2 weeks as for the other group but without ice packs.</description>
    <arm_group_label>patient with game-ready splint</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>shoulder arthroplastis</intervention_name>
    <description>- Group (Control): Placement of a standard splint immediately after surgery for 2 weeks with ice packs to be used for an average of 8 days.</description>
    <arm_group_label>patient with standard splint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. First-line reverse prosthesis&#xD;
&#xD;
          2. Without prosthetic history&#xD;
&#xD;
          3. Patient who has given his consent to participate in the observational study after&#xD;
             being informed by the surgeon&#xD;
&#xD;
          4. Patient living in France and able to answer the questionnaire alone.&#xD;
&#xD;
          5. Subject affiliated to a social security scheme or beneficiary of such a scheme&#xD;
&#xD;
          6. Lack of participation in another clinical study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Minor patient&#xD;
&#xD;
          2. Major subject protected by law, under curatorship or tutorship&#xD;
&#xD;
          3. Anterior prosthesis&#xD;
&#xD;
          4. Infection&#xD;
&#xD;
          5. Parkinson's, degenerative neurological disease&#xD;
&#xD;
          6. Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>philippe VALENTI, DOCTOR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Bizet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>bouchra benkessou</last_name>
    <phone>0033143967823</phone>
    <email>b.benkessou@clinique-bltparis.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>imen NID TAHAR</last_name>
    <phone>0033143967823</phone>
    <email>imen.arc@institutparisienepaule.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bizet Clinic</name>
      <address>
        <city>Paris</city>
        <zip>75016</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>benkessou BOUCHRA</last_name>
      <phone>0764486016</phone>
      <email>b.benkessou@cliniques-bltparis.fr</email>
    </contact>
    <investigator>
      <last_name>valenti philippe, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

